Page 87 - Bio News Today

An Evansville man has been arrested for a string of thefts from vehicles in Owensboro. On Wednesday at 12:48am...

The Indiana Supreme Court issued a public reprimand today for Attorney General Todd Rokita for his public comm...

Bio-Rad Laboratories (NYSE:BIO – Get Free Report) was downgraded by investment analysts at StockNews.com from a “buy” rating to a “hold” rating in a research report issued to clients and investors on Monday. Several other analysts have also issued reports on BIO. Wells Fargo & Company cut their price objective on Bio-Rad Laboratories from $550.00 […]

Company to host conference call to discuss financial results and provide a corporate update on November 7, 2023 at 4:30 p.m. ET...

Rowland & Co. Investment Counsel ADV lessened its position in Bio-Rad Laboratories, Inc. (NYSE:BIO – Free Report) by 16.1% during the 2nd quarter, Holdings Channel.com reports. The institutional investor owned 1,227 shares of the medical research company’s stock after selling 235 shares during the quarter. Rowland & Co. Investment Counsel ADV’s holdings in Bio-Rad Laboratories […]

Owensboro, KY (October 30, 2023) - OVG360, the providers of Venue Management to the Owensboro Convention Cente...

After idling half the state’s normal rice acreage last year due to water shortages, farmers are back in full force in California’s Sacramento Valley, and Syngenta Ordered to Sell Arkansas Farmland

Bio-Rad Laboratories (NYSE:BIO – Get Free Report) announced its quarterly earnings results on Thursday. The medical research company reported $2.33 EPS for the quarter, missing the consensus estimate of $2.87 by ($0.54), Briefing.com reports. Bio-Rad Laboratories had a negative net margin of 5.86% and a positive return on equity of 3.82%. The firm had revenue […]

After idling half the state’s normal rice acreage last year due to water shortages, farmers are back in full force in California’s Sacramento Valley, and Syngenta Ordered to Sell Arkansas Farmland

CHA Medical and Bio Group hosted a forum featuring international researchers in the field of cell and gene therapy (CGT) to share the latest research findings and discuss the potential of CGT to treat rare and intractable diseases, the bio group said Friday.